Danish weight loss drug maker outlines ambitious 2030 strategy, ramping up pressure on Novo, Lilly (2025-12-11)
Growing competition from smaller players is tightening the race for market leaders Novo Nordisk and Eli Lilly as more weight loss medicines near market entry.